T1	p 100 135	ADHD and Autism . Attention deficit
T2	p 172 196	autism spectrum disorder
T3	p 199 202	ASD
T4	p 612 673	Age-matched boys with ADHD ( 15 ) , ASD ( 18 ) , and controls
T5	p 980 988	Patients
T6	p 1117 1140	ASD boys underactivated
T7	p 1345 1353	ASD boys
T8	i 24 34	Fluoxetine
T9	i 337 356	reuptake inhibitors
T10	i 711 746	magnetic resonance imaging ( fMRI )
T11	i 818 853	acute dose of Fluoxetine or placebo
T12	i 874 892	placebo-controlled
T13	i 1077 1081	fMRI
T14	i 1107 1114	placebo
T15	i 1281 1291	Fluoxetine
T16	i 1421 1428	placebo
T17	i 1491 1501	Fluoxetine
T18	o 38 73	Medial Prefrontal Cortex Activation
T19	o 136 158	hyperactivity disorder
T20	o 172 196	autism spectrum disorder
T21	o 203 239	) share brain function abnormalities
T22	o 247 268	cognitive flexibility
T23	o 380 389	cognitive
T24	o 414 422	behavior
T25	o 1121 1174	boys underactivated medial prefrontal cortex ( mPFC )
T26	o 1252 1280	precuneus activation . Under
T27	o 1294 1309	mPFC activation
T28	o 1314 1330	up-regulated and
T29	o 1381 1395	down-regulated
T30	o 1535 1550	mPFC activation
T31	o 1562 1566	ADHD